Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
| Actual shortage: | 246 (8%) | |
| Anticipated shortage: | 15 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2018-10-11 | 2019-06-08 | 63796 |
| APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2018-10-19 | 2019-02-06 | 64956 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2019-01-03 | 2019-01-17 | 71148 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2019-01-09 | 2019-02-13 | 71659 |
| APO-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2019-02-06 | 2019-04-25 | 74867 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2019-02-06 | 2019-03-07 | 74932 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2019-03-05 | 2019-04-05 | 77875 |
| APO-FLUCONAZOLE-150 | 150MG | CAPSULE | Resolved | 2019-03-05 | 2019-04-26 | 77884 |
| APO-SERTRALINE | 50MG | CAPSULE | Resolved | 2019-04-04 | 2020-03-27 | 80539 |
| APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2019-04-24 | 2019-05-31 | 82334 |
| APO-PREGABALIN | 150MG | CAPSULE | Resolved | 2019-05-08 | 2019-06-17 | 83527 |
| APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2019-05-15 | 2019-05-25 | 84108 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2019-05-15 | 2019-06-01 | 84112 |
| APO-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2019-05-22 | 2019-11-11 | 84532 |
| APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2019-05-29 | 2020-03-02 | 85161 |
| APO-RIVASTIGMINE | 4.5MG | CAPSULE | Resolved | 2019-06-05 | 2019-10-07 | 85610 |
| APO-SERTRALINE | 50MG | CAPSULE | Resolved | 2019-06-05 | 2020-03-09 | 85613 |
| APO-RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2019-06-12 | 2019-10-07 | 86336 |
| APO-DABIGATRAN | 110MG | CAPSULE | Resolved | 2019-06-26 | 2022-10-07 | 87509 |
| APO-RIVASTIGMINE | 6MG | CAPSULE | Resolved | 2019-07-03 | 2019-10-07 | 88360 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
| APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
| APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
| APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |
| APO-LISINOPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60579 |
| APO-LISINOPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-26 | 60582 |
| APO-LISINOPRIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60585 |
| APO-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
| APO-LORAZEPAM | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60597 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60600 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |
| APO-MEDROXY TABLETS | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60609 |
| APO-MELOXICAM | 7.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60612 |
| APO-MEMANTINE | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60615 |
| APO-METOPROLOL | 25MG | TABLET | To be discontinued | 2018-09-07 | 2021-06-03 | 60628 |
| APO-METOPROLOL | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-01-09 | 60631 |
| APO-METOPROLOL (TYPE L) | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60634 |
| APO-MYCOPHENOLATE | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-10-12 | 60640 |